Dystrophic Epidermolysis Bullosa Latest Advances
Find the Latest Research About Dystrophic Epidermolysis Bullosa
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1759 publications
Alterations in Gut Microbiome Diversity and Composition in Patients with Epidermolysis Bullosa: A Case-Control Study.
Journal: Indian journal of dermatology
Published: September 08, 2026
Anesthetic management of two children with dystrophic epidermolysis bullosa undergoing emergency abdominal surgery.
Journal: Minerva anestesiologica
Published: September 04, 2026
Rigosertib Reverses Hypertrophic Cardiomyopathy in Noonan Syndrome.
Journal: Circulation
Published: August 18, 2026
Neonatal Skin Blistering and Denudement Caused by Epidermolysis Bullosa.
Journal: Cureus
Published: August 04, 2026
Transcriptional-secretory uncoupling in RDEB skin creates a non-permissive microenvironment for sensory nerve regeneration.
Journal: Neurobiology of pain (Cambridge, Mass.)
Published: June 19, 2026
Identification of a long-term surviving human mesenchymal stromal cell subpopulation and implications for recessive dystrophic epidermolysis bullosa treatment.
Journal: Stem cell research & therapy
Published: June 01, 2026
Challenges of Ontology-Based Concept Normalization for Deep Phenotyping in Rare Skin Diseases.
Journal: Studies in health technology and informatics
Published: May 23, 2026
Impact of modified SSD soft brace on surgical outcomes and wound healing duration following hand scar contracture release in RDEB patients.
Journal: Frontiers in surgery
Published: May 10, 2026
Preserved Foot Function After Repeated Surgical Intervention in Recessive Dystrophic Epidermolysis Bullosa: A 17-Year Follow-Up.
Journal: The Journal of dermatology
Published: May 08, 2026
Revisiting Type VII Collagen Mislocalisation in Dystrophic Epidermolysis Bullosa Using High-Resolution Imaging.
Journal: Experimental dermatology
Published: April 27, 2026
Successful Treatment of Dystrophic Epidermolysis Bullosa With the JAK1 Inhibitor Abrocitinib.
Journal: Journal of drugs in dermatology : JDD
Published: April 03, 2026
Last Updated: 09/26/2026